RYTMRHYTHM PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of RHYTHM PHARMACEUTICALS, INC. against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RYTM본 종목 | $6.8B#4 | — | 55.4x#5 | 35.9x#3 | 45.8%#3 | 24.6%#3 | -101.2%#3 | -0.2%#2 | -113.5%#4 | — | 16.5%#2 | — |
| TGTX | $7.9B#3 | 18.1x#1 | 13.6x#3 | 12.9x#1 | 87.3%#2 | 1811.1%#1 | 20.0%#1 | 76.7%#1 | 13.9%#1 | — | 46.1%#1 | — |
| PTGX | $8.8B#2 | — | 13.4x#2 | 191.2x#4 | -89.4%#5 | -147.3%#5 | -343.6%#4 | -19.9%#4 | -33.5%#2 | — | — | — |
| ARWR | $11.9B#1 | — | 19.4x#4 | 14.4x#2 | 23258.2%#1 | 99.7%#2 | 11.9%#2 | -0.3%#3 | — | — | — | — |
| COGT | $6.6B#5 | — | 10.9x#1 | 844.7x#5 | -65.0%#4 | -28.6%#4 | -4235.3%#5 | -54.1%#5 | -81.2%#3 | — | — | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-08-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice